Piétu G, Ribba A S, Meulien P, Meyer D
INSERM U. 143, Hôpital de Bicêtre, le Kremlin Bicêtre, France.
Biochem Biophys Res Commun. 1989 Aug 30;163(1):618-26. doi: 10.1016/0006-291x(89)92182-7.
We have used an in vitro transcription-translation system to localize the epitope corresponding to a monoclonal antibody (MAb 418) to vWF which specifically inhibits its binding to F. VIII. We have subcloned 1.5 Kb of vWF cDNA encoding for the N-terminal part of the vWF subunit which contains a binding site for F.VIII into the Bluescribe expression vector. After in vitro transcription and translation using the resulting construction (pBS-TG3522), a polypeptide of mol wt 60,000 (AA 1-495) was immunoprecipitated with a polyclonal antibody to vWF and with MAb 418. The MAb 418 epitope was further localized by reducing the size of the cDNA insert. This resulted in the production of two polypeptides of 18,000 (AA 1 to 142) and 13,000 (AA 1 to 106) which both retained reactivity with MAb 418. Thus the epitope corresponding to MAb 418 is localized to the first 106 AA of the mature vWF subunit.
我们使用了一种体外转录-翻译系统,将与单克隆抗体(MAb 418)对应的表位定位到血管性血友病因子(vWF)上,该单克隆抗体可特异性抑制vWF与因子VIII(F. VIII)的结合。我们已将编码vWF亚基N端部分(包含F.VIII结合位点)的1.5 Kb vWF cDNA亚克隆到蓝舌病毒表达载体中。使用所得构建体(pBS-TG3522)进行体外转录和翻译后,用抗vWF多克隆抗体和MAb 418免疫沉淀分子量为60,000的多肽(氨基酸1-495)。通过减小cDNA插入片段的大小,进一步定位了MAb 418表位。这导致产生了两种多肽,分子量分别为18,000(氨基酸1至142)和13,000(氨基酸1至106),它们都与MAb 418保持反应性。因此,与MAb 418对应的表位定位于成熟vWF亚基的前106个氨基酸。